Biossil exits stealth with $70 million USD to give failed medicines a second chance

Biossil exits stealth with $70 million USD to give failed medicines a second chance

Summary

The Toronto-based biotech startup counts OpenAI, Founders Fund, and Staircase Ventures as backers.

Description

The Toronto-based biotech startup counts OpenAI, Founders Fund, and Staircase Ventures as backers.

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source

Related coverage